Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biotechnology company Genzyme has initiated expansion of its flagship manufacturing facility at Allston Landing in Boston. The $150 million project is focused on adding space for manufacturing support functions, and aims to create 90 jobs.
Subscribe to our email newsletter
Henri Termeer, chairman and CEO said: “The expansion of Allston Landing will help sustain the continued growth of Genzyme’s products. It will enable us to continue to fulfill our long-term commitment to deliver these life-saving treatments to patients around the world.”
The expansion project includes 86,000 square feet of new office and manufacturing-support space. Genzyme is also building a 26,000 square foot underground co-generation facility, which will generate steam to run the plant’s process operations and will also produce electricity.